Condition: Acute Myeloid Leukemia · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
This study aims at evaluating the safety and the tolerance of the micro-transplantation in elderly patients with acute myeloid leukemia who are ineligible to conventional allogeneic transplantation.
This description comes directly from the study's public registry record.
Jérôme Cornillon, MD · 04 77 91 67 26 · jerome.cornillon@chu-st-etienne.fr
Elisabeth Daguenet, PhD · 04 77 91 70 89 · elisabeth.daguenet@chu-st-etienne.fr
Always discuss trial participation with your own doctor first.
| CHU Estaing | Clermont-Ferrand, France | Recruiting |
| Centre Hospitalier Universitaire de Grenoble | Grenoble, France | Recruiting |
| CHRU de Lille | Lille, France | Not Yet Recruiting |
| Centre Hospitalier Lyon Sud | Lyon, France | Recruiting |
| Centre Hospitalier Universitaire de Nancy | Nancy, France | Not Yet Recruiting |
| Hôpital de la Pitié-Salpêtrière | Paris, France | Not Yet Recruiting |
| CHU de Saint-Etienne | Saint-Etienne, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03439371